Gene Therapy Trial for Mitochondrial Disease of Retina Found Safe, Can Continue
News
An independent Data Safety Monitoring Board (DSMB) has found GS030, GenSight Biologics’ candidate gene therapy for retinitis pigmentosa, safe and recommended the ... Read more